Related Experiment Videos
Regulatory issues for clinical gene therapy trials
Kenneth Cornetta1, Franklin O Smith
1Departments of Medicine, Microbiology and Immunology, and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. kcornett@iupui.edu
Human Gene Therapy
|July 23, 2002
Summary
Human gene therapy trials face strict regulations. This review covers human subject research principles, oversight bodies, and regulatory challenges for academic gene therapy research.
Area of Science:
- Biomedical Research
- Clinical Trials
- Gene Therapy
Background:
- Gene therapy clinical trials are subject to extensive regulatory oversight.
- Understanding the fundamental principles of human subject research is crucial for compliance.
- Academic researchers in gene therapy navigate a complex regulatory landscape.
Purpose of the Study:
- To review the basic tenets of human subject research.
- To discuss the regulatory bodies overseeing gene therapy trials.
- To outline challenges faced by academic researchers due to new and proposed regulations.
Main Methods:
- Literature review of existing regulations and guidelines.
- Analysis of the regulatory framework for human subject research.
- Discussion of challenges impacting academic gene therapy investigators.
Main Results:
- Gene therapy trials are among the most heavily regulated.
- Key regulatory bodies and their oversight functions are identified.
- Specific challenges posed by current and upcoming regulations are highlighted.
Conclusions:
- Adherence to human subject research principles is paramount in gene therapy.
- Navigating regulatory complexities is essential for academic gene therapy research progression.
- Awareness of evolving regulations is critical for investigators.